HomeValvular Aortic valveMitral valve

Mitral valve

View Category

Mitral valve

New Advances in Mitral Regurgitation Devices with Promising Results

Mitral regurgitation (MR) is a frequent valvulopathy and when the optimal medical treatment at maximum tolerated doses...
solaci -
Learn More
Mitral valve

TCT 2023 | CLASP IID Study 1-Year Results: PASCAL vs. MITRACLIP for Degenerative Mitral Regurgitation

The negative impact of mitral regurgitation (MR) on patient mortality, morbidity, and quality of life is widely...
solaci -
Learn More
Mitral valve

TCT 2023 | TRILUMINATE Trial: Health Status after TriClip

Severe tricuspid regurgitation (TR) has been associated with higher mortality, increased risk of hospitalization for cardiac failure...
solaci -
Learn More
Mitral valve

TCT 2023 | EXPAND G4

The EXPAND G4 is a prospective multicenter single arm study on real life patients.  It included a total...
solaci -
Learn More
Mitral valve

MITRAL Trial, Results at 5 Years

Repeat mitral valve repair has been associated with increased mortality. Transcatheter mitral valve repair has surged as...
solaci -
Learn More
Mitral valve

TRILUMINATE Two Years In: Encouraging Results

Tricuspid valve regurgitation is more common than one might think. It often stems from left valve disease...
solaci -
Learn More
Mitral valve

Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient

Primary or degenerative mitral regurgitation (MR) occurs frequently. Even though surgery continues to be the standard treatment...
solaci -
Learn More
Highlighted Presentations

SOLACI-SBHCI 2023 | Mitral Valve Interventions beyond the TEER Era: Time to Re-Evaluate Innovation Priorities?- Dr. Eberhard Grube

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Eberhard...
solaci -
Learn More